HUMAN PAPILLOMAVIRUS
Clinical trials for HUMAN PAPILLOMAVIRUS explained in plain language.
Never miss a new study
Get alerted when new HUMAN PAPILLOMAVIRUS trials appear
Sign up with your email to follow new studies for HUMAN PAPILLOMAVIRUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New triple therapy targets Hard-to-Treat cancers
Disease control OngoingThis study tests a combination of three drugs—bintrafusp alfa, PDS01ADC, and entinostat—in adults with advanced HPV-related cancers (like cervical, anal, or throat cancer) or certain colon cancers that haven't responded to standard treatment. The goal is to find a safe dose and s…
Matched conditions: HUMAN PAPILLOMAVIRUS
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Can a probiotic gel help women clear HPV and early cervical lesions?
Disease control OngoingThis study tests whether a natural vaginal gel called CH2 can help women with mild cervical changes (CIN1) and high-risk HPV clear the infection and heal faster. Fifty women will use either the gel or a placebo twice a week for 24 weeks. Researchers will track Pap smear results a…
Matched conditions: HUMAN PAPILLOMAVIRUS
Phase: NA • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC